- Home
- PRCT vs IRMD Comparison
PRCT vs IRMD Comparison
Compare PRCT & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRCT | IRMD |
|---|---|---|
| Founded | 2009 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PRCT | IRMD |
|---|---|---|
| Price | $27.27 | $85.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $35.44 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 1.2M | 89.5K |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | 1.71 | ★ 16.67 |
| EPS | N/A | ★ 0.45 |
| Revenue | ★ $308,054,000.00 | $83,814,000.00 |
| Revenue This Year | $31.34 | $12.38 |
| Revenue Next Year | $24.52 | $11.31 |
| P/E Ratio | ★ N/A | $191.03 |
| Revenue Growth | ★ 37.22 | 14.43 |
| 52 Week Low | $19.35 | $50.88 |
| 52 Week High | $64.89 | $107.90 |
Technical Indicators
Market Signals| Indicator | PRCT | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.96 | 34.66 |
| Support Level | $22.05 | $82.64 |
| Resistance Level | $29.06 | $87.54 |
| Average True Range (ATR) | 1.64 | 3.70 |
| MACD | 0.36 | 0.11 |
| Stochastic Oscillator | 97.38 | 46.86 |
Price Performance
Historical ComparisonAbout PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.